# BRIUMVI
> **BLA761238** · Biologics License Application · Sponsor: TG THERAPEUTICS, INC · Approved 2022-12-28
## Drug
- **FDA Application Number:** BLA761238
- **Application type:** Biologics License Application
- **Brand name:** BRIUMVI
- **Generic name:** UBLITUXIMAB
- **Active ingredients:** UBLITUXIMAB-XIIY
- **Dosage form:** INJECTABLE
- **Route:** INTRAVENOUS
- **Marketing status:** Prescription
- **Sponsor:** TG THERAPEUTICS, INC
- **Manufacturer:** TG Therapeutics, Inc.
- **First approval:** 2022-12-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=761238)
---
*AI Analytics · CC0 1.0*